IVOSKIN, a science-driven skincare brand, officially launched its "Intensive Cica Repair Cream" in January, targeting ...

Patients with atopic dermatitis experienced improvements in severity with 16 weeks of tralokinumab despite the number of ...

The International Medical Derm Summit 2025 highlighted China's dermatological advancements, fostering global collaboration ...

Treatment with dupilumab is associated with weight gain in about two thirds of adults with atopic dermatitis over 3-6 months, ...

With few real-life studies that have specifically focused on how atopic dermatitis (AD) affects patients living with the ...

One in 10 people with atopic dermatitis, the most common type of eczema, have symptoms on their feet. These quick facts can help you manage it.

We chatted with dermatologists to find out what LED light therapy devices can and cannot do for your skin when it comes to eczema.

Apogee Therapeutics Inc. (NASDAQ:APGE) is one of the best oversold NASDAQ stocks to buy now. On July 11, BTIG analyst Julian ...

Intermittent treatment with pimecrolimus over 1 year significantly reverses corticosteroid-induced skin atrophy and ...

Young patients with atopic dermatitis prioritize different treatment goals and have varying preferences from their caregivers.

Apogee Therapeutics’ anti-IL-13 antibody has been tied to a 71% reduction in eczema severity after 16 weeks, hitting the main ...

The antibody treatment could compete with Sanofi’s Dupixent and Eli Lilly’s Ebgylss, while offering the potential for less ...